GINGERA MIDLIFE, UNDERSTOOD
← The reading room
The transition · 17 MIN READ

Should Hormones Start at 35? A Debate Among Doctors Abroad

Full original restored

Periods, sleep and temperature sensations may change, but no two paths are identical. Understanding the transition leaves room for other explanations too.

Editorial image
In this article
Complete manuscript restored from the archive, with a full English translation. Original medical claims have been preserved for review; medical and regional terminology review remain pending. This is educational reading, not individual medical advice.

Original article illustration

The folded examination gown at the corner of the consultation desk, and the chair that remains empty

1. The sentence in the consultation room: "I saw online…"

A woman in her early forties enters the consultation room, sits down, and puts her phone on the desk. After a few pleasantries, her first sentence is an opening increasingly familiar in clinics in recent years:

"Doctor, I saw online that someone my age should start hormones early, because they will not work if I leave it too late. Is that true?"

She explains further. She is forty-one; over the past six months her sleep has become lighter, she tires during the day, her mood has been particularly unstable for a while, and her period sometimes arrives a few days early. Accounts she follows tell her these are perimenopause, and that after 35 she "should begin hormone assessment" or risk missing the window. She has also seen recommendations for "hormone testing" said to reveal whether perimenopause has begun.

Her phone contains three or four links with similar titles: "Do not endure it," "The earlier the better," "Do not wait until it is too late."

The doctor opposite her is probably fighting an internal battle too.

A doctor aligned with one side might say, "Yes, these symptoms are typical; we can consider menopausal hormone therapy." Someone aligned with the other might say, "At your age, many people's symptoms come from insufficient sleep and stress. Do not rush into medication." Both sides can offer apparently reasonable arguments.

This article will not "give you the answer," because abroad even doctors do not yet share one answer. A real debate is taking place publicly, with substantial voices on both sides.

Despite the debate, patients can take away clear information: facts acknowledged by both sides, errors to avoid, and questions to bring to a consultation.

Let us begin with the debate itself.

2. Mechanism and background: what is the argument really about?

2.1 The central controversy: is this a "disease"?

To understand the debate, identify its central question. On the surface it concerns "whether to use hormones," but underneath lies something deeper:

Is perimenopause a "health-risk window" requiring medical intervention, or a "normal physiological transition" repackaged by modern commerce and social media?

The difficulty is that both answers have support.

Calling it a "normal physiological transition" is biologically indisputable. Menopause is a natural process every woman experiences, not a disease, abnormality, or bodily defect needing "treatment." Precisely because it was regarded as "not a disease," however, women's health needs at this stage were neglected and dismissed for decades with "just endure it and it will pass." That itself is profoundly unfair.

Calling it a "health window warranting intervention" also has strong reasons. Perimenopause brings real discomfort—hot flashes, night sweats, sleep disturbance, mood fluctuations, reduced attention, and joint discomfort—that may seriously impair work and daily function. It also brings longer-term changes such as accelerated bone loss and altered metabolic and cardiovascular risk factors. Intervention can substantially improve quality of life for some people.

The real dispute is therefore not "whether it is natural," but boundaries: whose symptoms justify treatment? How far should nonhormonal approaches come first? Where do women aged 35 or 40, or those with very mild symptoms, fit?

2.2 What critics say

Their central accusation is: a force is overmedicalizing a normal physiological transition and profiting from it.

Their specific arguments commonly include the following:

First, the audience has expanded beyond appropriate boundaries. Social-media content persuades many women in their thirties with mild symptoms or none to seek hormone therapy and related testing. They did not originally think anything was "wrong"; after enough exposure, they reinterpret common discomforts—tiredness, poor sleep, poor concentration—as "perimenopause."

Second, there is a repeatable persuasion pathway. Start with a description of distress ("Do you feel this too?"), supply a single explanation ("This is perimenopause"), then offer a solution ("You need hormones"). This is highly efficient because it addresses genuine difficulties—but modern life has many causes for them: sleep debt, workload, caregiving, insufficient exercise, emotional problems, thyroid disease, anemia, and more.

Third, the trend has community-based characteristics. A landmark critical article in MIT Technology Review in July 2026 made this explicit. Titled There's a lot of hype around perimenopause. Don't buy it., it included three key judgments: there is no reliable "perimenopause test"; the applicability of hormone therapy to "perimenopause" is much less clear than to "postmenopause"; and the trend has "cult-like" community characteristics.

"Cult-like" is a strong term, but describes structure, not intelligence. When a topic combines a single narrative explaining all your discomfort, authoritative opinion leaders, explicit action instructions, an insider–outsider boundary of "outsiders do not understand us," and products and services requiring continued payment or participation, its behavior begins to resemble a small community rather than a medical discipline. Independent judgment becomes difficult within that structure, regardless of intelligence.

The most important sentence to remember from that article:

There is no reliable "perimenopause test." In the context of 2026 this matters particularly because "testing" is easily commercialized: it can be priced, packaged, and presented as an apparently objective number.

2.3 What supporters say

Quoting only critics would make this one-sided. Supporters' arguments also deserve serious attention and are often more powerful because they address a genuine historical deficit.

First: this is overdue compensation for decades of neglect of women's health. Women's health research has long lacked resources; findings based predominantly on male samples were applied to women, while menopause occupies very little medical education. Many women now seeking care were dismissed for twenty or thirty years with "endure it," "ignore it," or "it is normal." The other side of the trend is large numbers being heard seriously for the first time.

Second: earlier excessive caution itself caused harm. For a substantial period, excessive fear surrounded menopausal hormone therapy, discouraging women who could have benefited and leaving many symptomatic women without any help. Supporters see current attention as a rebound from that suppression, directionally right: what needs attention is proportion, rather than direction.

Third: "a normal physiological process" is not a valid reason to refuse intervention. Pregnancy, birth, and menstruation are not diseases, yet modern medicine offers extensive support and interventions. Menopause should be no exception. "This is normal" and "this needs no help" are entirely different statements.

The two sides are competing less over facts than over proportion. Proportion is particularly hard to explain in public education because it depends on the individual.

2.4 A third voice from forums

Reading professional media alone misses an important dimension: the people experiencing this have divided feelings.

Related forums and communities contain two simultaneous, authentic voices.

One says: "For the first time, I felt someone really listened." These people often experienced prolonged dismissal within formal healthcare: "it is your age," "nothing is wrong," "are you stressed?" or "perhaps see someone about your mental health first." Finally encountering an explanation that takes symptoms seriously creates a powerful sense of recognition. No one has the right to ridicule that.

The other says: "An oversimplified online narrative led me to a medical decision I now regret." These people often followed a suggested approach and either used something inappropriate or kept attributing a problem needing investigation to "perimenopause" until worsening symptoms revealed another cause.

Their coexistence honestly reflects the debate: this is not a choice between "the trend is good" and "the trend is bad." The value of recognition and the risk of misleading people are both real.

2.5 A change happening quietly

Another phenomenon deserves separate attention because it changes the most basic interaction in a consultation.

Social media is changing patients' consultation agendas. Increasingly, appointments begin with "I saw online…"

This is neutral in itself and largely positive: patients are more proactive, information asymmetry is reduced, and doctors can less easily dismiss them with "ignore it." But it creates new challenges for both sides.

For a doctor, there is insufficient time to respond to every piece of content a patient brings; a poor response leaves the patient feeling "dismissed again." For the patient, her entire consultation framework may have been supplied by an algorithm. Once the first question is asked, the possible answers are already constrained: she asks "Should I use hormones?" rather than "What is causing my symptoms?"

That is why the next thing we offer is a question list: better questions improve the quality of answers.

Original article illustration

A phone face down and an open notebook: what you saw online and what you actually asked

Age 35

The sharpest point of contention. Critics believe many women this age with mild or no symptoms are persuaded by content to seek intervention; supporters argue that decades of dismissive "just endure it" advice forced them to seek answers through social media.

What the two sides contest is not really the number 35, but whom "assessment" should be available to.

3. Evidence review: points both sides agree on

Despite the debate, some judgments are repeatedly confirmed across positions. They provide the most dependable foundation for assessing your situation.

3.1 There is no reliable "perimenopause test"

There is little dispute about this.

The physiological reason is clear: hormone levels fluctuate dramatically during perimenopause. A high or low result at one moment cannot reliably establish your stage or show whether hormones caused your symptoms. It is like trying to judge traffic on a road from one photograph taken at a single instant: too little information.

Original article illustration

A stack of still-blank laboratory forms: some questions are not answered by another test

One concrete clinical consequence is that someone may get "low hormones" at Hospital A and "normal" at Hospital B, pay twice, and still have no one able to give a consistent judgment from those numbers.

Common misunderstanding: a blood hormone test tells you whether you have entered perimenopause.

For most people over 40 with typical symptoms, judgment primarily relies on symptom patterns and menstrual changes, rather than an instantaneous hormone value. As explained, substantial fluctuations make a single measurement difficult to interpret. Your treating doctor should decide whether tests are needed and which, based on your circumstances.

Any service selling "professional perimenopause testing" and directly assigning a stage therefore warrants another question: How reliable is this result, and what decision can it change?

3.2 Symptoms are not unique: the source of missed diagnoses

Both sides acknowledge this, and it was the most cautionary part of a May 2026 Guardian report.

The report described clinical observations: some patients were pushed by social media to request medication they did not need; unintended pregnancies were mistaken for menopausal symptoms; and some underlying causes were missed.

These are different expressions of one problem: when "perimenopause" becomes an all-purpose explanation, it conceals other causes that should be investigated.

Fatigue, sleep disturbance, mood fluctuations, poor concentration, menstrual changes, palpitations, and weight changes can arise from many conditions, some requiring treatment. Perimenopause can indeed cause them, but "it may be perimenopause" must never become "therefore no investigation is needed."

A pattern of attribution to watch particularly carefully

Putting every symptom under one explanation, then stopping further questions.

Especially when a symptom is new, progressive, or clearly out of step with cycle changes, it should not be absorbed into "you have reached that age."

3.3 Treatment applicability differs

Another important, easily oversimplified judgment in the critical article is: hormone therapy is much less clearly applicable to "perimenopause" than "postmenopause."

Its full meaning needs explanation to avoid misreading it as "hormones cannot be used during perimenopause":

It means evidence strength and decision complexity differ by stage. Postmenopausal populations—with established cessation of periods and a stable low-hormone state—have a relatively clearer research base and consensus on indications, regimens, and monitoring. Perimenopause is more complex: hormones still fluctuate, periods continue, symptom sources overlap, and individual transitions differ. Decisions must therefore be more individualized, with greater opportunity for both "not treating someone who should be treated" and "treating someone who should not."

That is why this stage particularly needs "assessment" rather than "a formula."

3.4 Public discussion itself has brought benefits

Criticism should not obscure this.

Menopause was previously unspeakable in many cultures, leaving women to cope alone. Silence is now breaking: more people know symptoms have names, mechanisms, and management options; fewer see symptoms as "personal failure"; and discussion is emerging at work and in society.

A reasonable assessment is therefore: the direction is justified, while the methods have become clearly excessive. Both can be true.

4. Risks and controversies: four concrete costs of excessive attention

4.1 First cost: overlooking unnecessary-treatment risk

No medical intervention is risk-free. When content persuades someone to enter a consultation with the assumption "I want hormones," discussion narrows. Questions about "whether I might benefit," "what needs ruling out first," and "whether a non-drug approach suits me better" can shrink into "let me try a course."

A boundary must be explicit: whether to use treatment, which type, and for how long requires comprehensive assessment by your treating doctor based on symptom nature and severity, history, risk factors, and preferences. Content cannot decide it, including this article.

4.2 Second cost: missing the real cause

This is the most concerning of the four costs because it may cause actual delay.

Premature attribution skips the investigative pathway. Perimenopause happens to cover many common symptoms. If symptoms persist, progress, or clearly feel "wrong," do not let inquiry stop at "this is perimenopause."

A sentence to remember directly

"It may be perimenopause" is a

hypothesis requiring evaluation

, not a conclusion that ends further questions.

4.3 Third cost: community pressure impeding independent judgment

A strongly communal discussion creates subtle pressure.

Share hesitation and you may hear "perhaps you have not found the right doctor"; report mediocre results and hear "your dose is insufficient"; decline treatment and face suggestions that "you do not love yourself enough." When a health choice acquires moral or identity significance, independent judgment becomes very difficult.

This does not mean community participation is necessarily bad. Many gain genuine support and information and realize they are not alone. But preserve an exit: your community experience matters, while treatment decisions belong in the consultation room rather than the comments.

4.4 Fourth cost: spending in the wrong place

A market lies behind the trend. Expanded demand rapidly brings supply, of widely varying quality.

Common paid offerings include tests sold as "perimenopause testing," consultations called "assessments," subscriptions marketed as "personalized plans," and numerous wellness products. Their necessity and evidence bases differ greatly; some may simply repackage public information.

A simple test: if a service mainly produces a report and product recommendations, rather than a genuine medical assessment and follow-up plan, it probably resembles retail more than healthcare.

4.5 Which symptoms actually warrant a consultation?

These situations deserve a proper appointment

One: symptoms have begun affecting daily function. Poor sleep impairs work, mood fluctuations affect relationships, or hot flashes and sweating disrupt social and professional settings. This practical standard asks what symptoms actually affect, rather than how severe they "should" be.

Two: menstrual patterns have clearly changed. Cycles suddenly shorten or lengthen, flow changes significantly, or bleeding occurs between periods. These need assessment, not an assumption of normal transition.

Three: significant emotional or cognitive distress. Persistent low mood, anxiety, or markedly poorer concentration can be assessed and addressed independently, rather than all attributed to hormones.

Four: you are making major life decisions about this. For example, changing work, considering long-term medication, or purchasing services. Professional judgment independent of commerce is especially important then.

Five: you feel something is wrong. This should not be overlooked. Your observations of your own condition are valuable clinical information.

5. Practical advice: take a question list into the consultation

This is the most practical section. Its aim is not to help you "beat the doctor," but to turn "Should I use hormones?" into "What is happening in my case, and what choices do I have?"

5.1 Before the appointment: write down three things

Preparing for the appointment

One: a symptom list—for each, specify onset, frequency, duration, aggravating or relieving circumstances, and concrete effects on life (inability to sleep or work, affected relationships). "Impact" is most important because it is central to deciding whether intervention is needed.

Two: everything you use—prescriptions, over-the-counter drugs, supplements, Chinese patent medicines, meal replacements, and topical products. List everything. Patients often overlook this, but it directly affects medical judgment.

Three: your actual goal—what do you most want resolved: sleep, mood, hot flashes, or long-term health risk? Put the main goal first and state it clearly. Different goals lead to entirely different plans.

5.2 In the consultation: use these questions directly

Nine questions to bring with you

About diagnosis

  1. What possible causes do you consider for my current symptoms? Is perimenopause one explanation or the only one?

  2. Does anything need ruling out first? Do I need tests, and if so, what question would they answer?

  3. I heard there is no reliable "perimenopause test." Is that true? How should we interpret a result that does not match symptoms?

About choices

  1. Besides medication, what approaches fit my situation, and how strong is the evidence for each?

  2. If considering medication, am I likely to benefit? What might make it unsuitable?

  3. What benefits and risks does each approach have? Would your advice change depending on whether I prioritize symptom relief or long-term health?

About implementation and follow-up

  1. If we start management, when should I notice an effect? When would it count as "it should have worked but has not"?

  2. What needs monitoring, how often should I return, and what requires an earlier visit?

  3. Does a particular claim I saw online (state the exact claim) apply to me? If not, why?

About question 9:

Asking directly is safer and much more efficient than repeated searching at home. A good doctor will not regard questions as a nuisance—

clear questions can instead substantially improve the appointment's efficiency.

If your concerns are dismissed, you have the right to another doctor or a second opinion.

5.3 Three signals of whether you have found an appropriate doctor

First: how many questions they ask. A serious assessment covers symptom details, medical and family history, medication, life circumstances, and preferences. If you say one sentence and receive an order, that is ordering, not assessment.

Second: whether they acknowledge uncertainty. These decisions contain substantial uncertainty. A doctor willing to say "In your current situation I lean toward A, but B is possible; we can observe before deciding" is usually more trustworthy than one immediately certain.

Third: whether they offer "not acting" as an option. True shared decision-making must include "observe for now without intervention" and explain its conditions and risks. A consultation offering only one answer is not really offering a choice.

5.4 Three filters for the flood of content

First filter: does it say "you may" or "you definitely"? "These changes may occur at this stage" differs from "someone your age definitely has this problem." The first educates; the second sells.

Second filter: does it specify when to seek care? Responsible health content tells you what requires a doctor. If it offers a nonmedical solution to every discomfort, it has crossed its boundary.

Third filter: does it explain "why not everyone"? A claim valid for every person and symptom probably says very little.

A suggestion about mindset

Do not turn this into choosing sides.

You need neither reject every intervention to prove you are "scientific and rational" nor accept every approach to prove you "love yourself enough."

You need a doctor who understands your circumstances and a thorough conversation in which both parties speak honestly.

6. Conclusion: the real question is not "use it or not"

Return to that consultation room.

What did the forty-one-year-old ultimately receive? With a doctor willing to assess seriously, the conversation might run like this: first, questions about six months of sleep, work, family circumstances, precise menstrual changes, medication, and history. Then an explanation: some symptoms may indeed relate to hormones, others to scheduling, sleep debt, or stress. We will do a basic assessment and exclude what needs excluding. If you agree, we can begin with several changes that do not involve medication and review in a few weeks before deciding on further management.

This answer is not satisfying or decisive and may even disappoint. But it is a real medical process: it addresses her as a person, rather than "women in their forties" as a category.

That is the debate's true meaning for ordinary people.

The argument among doctors abroad concerns professional judgment about proportion: how wide to open intervention, for whom, and when. As a patient, you need not and cannot adjudicate it. You can do something more important: do not hand yourself over to either narrative; ask for an assessment addressing you personally.

Before leaving, confirm these three questions:

One: were my symptoms asked about seriously, rather than simply attributed?

Two: were multiple possibilities explained, rather than only one conclusion given?

Three: whether or not medication is used, do I have a clear follow-up plan?

Confirming these avoids risks on both sides: neither refusing potentially helpful care through fear nor following a trend into a decision you regret six months later.

Trends pass. You still need to care for your body.

Main reference sources

· MIT Technology Review, July 2026: There's a lot of hype around perimenopause. Don't buy it. A landmark text in this debate, arguing that no reliable "perimenopause test" exists, hormone therapy is less clearly applicable during perimenopause than postmenopause, and related discussion has cult-like community characteristics.

· The Guardian, May 2026: reporting on perimenopause misinformation and clinical observations, including social-media-driven requests for unnecessary medication, unintended pregnancy mistaken for menopausal symptoms, and missed underlying causes.

· Public discussions in Reddit r/Menopause and other online communities, showing the coexistence of "being heard seriously for the first time" and "regretting decisions based on oversimplified narratives."

· Clinical consensus descriptions of large hormonal fluctuations during perimenopause and the lack of a reliable single-test marker.

· Professional discussion of differences in the evidence base for menopausal hormone therapy in perimenopausal versus postmenopausal populations.

· Public discussion of longstanding underinvestment in women's health research and limited menopause content in medical education.

· Principles for interpreting observational studies: they suggest association, cannot directly establish causality, and cannot predict individual outcomes.

This article is health education, not individualized diagnosis or treatment advice. All judgments, tests, and treatment choices require comprehensive assessment by your treating doctor based on symptom characteristics, history, risk factors, and preferences. Seek timely care for persistent or progressive symptoms, marked menstrual changes, bleeding between periods, or significant emotional distress. Do not diagnose or medicate yourself from online content alone. No specific drug, product, or service is recommended.

Editorial recordClinical review pending

Sources and review scope

Editorial author
Gingera Editorial
Clinical reviewer
Not yet assigned
Citation date check
Pending; source publication dates are not recorded here.
Risk note
High: avoid turning age or symptoms into an automatic diagnosis or treatment recommendation.

Questions for the clinical reviewer

  • Natural menopause is commonly identified retrospectively after 12 months without a period when no other cause applies.
  • Symptoms alone do not identify a single cause or establish a need for treatment.
  • Claims about consumer testing and hormone therapy need current guideline wording.
Report a content issue

Do not include health details, names, contact information or medical records. This report is sent to the editorial team.

This record lists review questions and citations. It does not mean a clinician has reviewed or approved the article.

Published correction log

  1. Loading correction history…
SOURCE NOTES

Read the source material

The original archive manuscript is restored above. These additional references offer context; their inclusion does not constitute medical validation of every original claim. Clinical and regional terminology review are pending.

GINGERA / COMMUNITY

A good question starts a conversation.

Explore a related editorial discussion. Reading is open to everyone; posting and replying require a free reader account.

Create a free accountDiscuss the transition